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Abstract 
Background: The Herpes virus is ubiquitous in our patient population. Often it is present without 
symptoms, however, it may present with pain, irritation, and decreased vision. In high-risk populations a 
longer course of treatment is often required. 
Case Report: This case report will detail the treatment options and outcome in a patient with herpes 
keratitis who also is HIV positive and addresses concerns about treating immunocompromised patients. 
Conclusion: This case serves as a review of common and uncommon treatment options for herpes 
keratitis as well as a review of potential causes of this presentation. Herpetic keratitis is likely to be 
something most providers will encounter during their careers. Use of oral antivirals is often more cost 
effect, better tolerated, and improves compliance. 
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  Herpes simplex keratitis (HSK) presents after a patient has been exposed to 
outside viral particles or after reactivation of the herpes simplex virus type 1 (HSV-
1) in their cornea. The cornea may respond differently depending on the anatomical 
location involved.1Pertinent terminology may vary widely from one practitioner to 
another2 and thus often results in inconsistent diagnosis and treatment from one 
provider to another. The condition typically presents in otherwise healthy 
individuals due to the almost ubiquitous presence of the virus within patients as 
they age. 1,3,4 
 
CASE REPORT  
 
  A 39-year-old African American male presented April 17, 2018 with complaints 
of redness, photophobia, and decrease in vision in his left eye for about one week. 
The patient reported being hospitalized for an unknown infection the previous 
week. Systemic history review revealed a positive history of HIV that was being 
treated with Norvir® (generic: ritonavir), Prezista® (generic: darunavir), and 
Tivicay® (generic: dolutegravir) that he was taking with good compliance. These 
medications are a part of the oft noted “HAART” therapy. While he did not recall 
his most recent CD4 he thought it was “above 1600” and that his viral load was 
undetectable at his last examination. He noted an allergy to azithromycin. A further 
review of systems revealed that he had recently felt fatigued and that he has asthma. 
The patient noted a history of redness in both eyes that occurred intermittently and 
usually only lasted a day or two and resolved without the need for intervention. He 
denied needing glasses. The patient was oriented to time, place, and person.  
 
  His distance vision upon initial examination was OD: 20/200 and OS: 20/25. The 
use of a pinhole did not improve his vision in the right eye. His pupils were round 
and reactive to light and accommodation. Extra ocular motilities (EOM) had full 
range of motion in both eyes without pain or diplopia. Confrontation visual fields 
(CFV) were full to finger counting in both eyes. Intraocular pressures were 11 mm 
Hg in the right eye and 15 mm Hg in the left eye with a Tonopen at 10:11a m.. 
Anterior segment examination revealed 2+ injection on the right bulbar 
conjunctiva, and trace injection on the left bulbar conjunctiva. The adnexa was 
unremarkable with normal lids and lashes OU; the cornea in the right eye took stain 
(Figure 1) and the left eye was negative for staining; irises were brown OU, anterior 
chamber was without cells or flare, angles were open by Van Herick (4/4 OU), and 
lenses were clear OU.  
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                      Figure 1. The differential diagnoses considered in this case include:2 
  
  
• Corneal abrasions can be present in patients of any age. However, they 
often occur as a result of trauma or at least mechanical manipulation of 
the eye. They are painful and can resolve either following intervention 
or without it. 
• Recurrent corneal erosions occur after an initial corneal insult. They 
typically occur upon awakening and will recur on an often infrequent 
and inconsistent time schedule. They occur as a result of damage to the 
corneal epithelium or epithelial basement membrane.  
• Vaccinia keratitis can occur following an inoculation or exposure to 
smallpox. Vaccinia can be shed from the location of exposure and can 
be spread by contact to the eye or periocular region.  
• Acanthamoeba keratitis is considered when the pain is disproportionate 
to the patient’s ocular appearance (high pain with minimal findings). 
Early in the disease process pseudodendrites can appear on the cornea.  
• Bacterial keratitis can result from ocular exposure to one of many 
bacteria most commonly Staphylococcus, Streptococcus or 
Pseudomonas. Frequently this presents with concurrent mucopurulent 
discharge and anterior chamber reaction.  
• Herpes Zoster keratitis can present with corneal pseudodendrites 
(Figure 2), however the keratitis typically presents following the 
presentation of a skin rash. The timing of the presentation can vary in 
immunocompromised patients. In the past, presentation of HZO in 
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patients less than 40 years of age was thought to be a potential signifier 
of HIV.  
• Herpes Simplex keratitis presents as a reactivation of the human herpes 
virus type-1 and is thought to be brought on by fever, stress, trauma, or 
ultraviolet light exposure. If keratitis is present, it is represented by 
“true” dendrites with positive stain.  
 
  The patient denied any known insult, traumatic or mechanical. While having 
experienced infrequent bouts of red eye in the past, each had resolved within a 
couple of days. The patient denied any known exposure to smallpox or its vaccine. 
His presentation revealed no mucopurulent discharge. This left Acanthamoeba, 
Herpes Zoster, and Herpes Simplex as potential causes. There were no skin lesions 
present however as indicated above, the keratitis can occur prior to dermatomal 
rash. The stained corneal lesions were consistent with presentation of true dendrites 
and thus a diagnosis of Herpes Simplex Keratitis was given. When distinguishing 
true dendrites from pseudodendrites, one must focus on the presence or absence of 
“terminal bulbs,” widenings at the end of the lesion. Additionally, it is helpful to 
look for ulceration of dendrites.  
 
  The patient was started on oral acyclovir 400 mg 5x/day and trifluridine 9x/day 
while awake. The patient was educated to the diagnosis and its prognosis (good). 
The patient was unable to obtain the trifluridine from the pharmacy as it was not in 




FOLLOW UP #1 
 
  The patient did not attend the initially scheduled follow up due to transportation 
difficulty. He instead returned one week from the initial visit. Upon presentation on 
April 24, 2018, he denied any change in his medical history. He noted some 
improvement in the vision in his right eye but denied much improvement in 
photophobia and irritation. His distance vision in the right eye had improved from 
20/200 to 20/60. His pupils, confrontation visual fields and extra ocular motilities 
were all unchanged and normal OU. His intraocular pressures were 10 mm Hg and 
12 mm Hg via Goldmann applanation tonometry at 10:30 am. His right eye still had 
2+ injection. The corneal dendrites showed no significant change in appearance. 
Upon follow up questioning the patient admitted to poor compliance with the oral 
acyclovir due to the frequency of dosing necessary. The dilated exam revealed no 
posterior segment involvement. He had clear vitreous OU; cup to disc ratio of 0.25r 
with sharp margins OU; flat macula OU; normal vessels and no holes or tears in 
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the periphery in both eyes. His medication was changed to oral valacyclovir 500 
mg 2x/day. Due to the patient’s complaint of mildly worse pain, a prescription of 
homatropine 5.0% BID, OD was added. Additionally, gentle corneal debridement 
of the infected epithelium was performed with fair success. Much of one dendrite 
was successfully removed while only some of the second dendrite could be 
removed. Due to the lack of improvement and the initiation of active intervention 
in office, the follow up was set for 3 days for the patient to be able to be seen prior 
to the weekend.  
 
FOLLOW UP #2  
 
  The patient followed up on April 26, 2018, and once again denied any changes in 
his medical history. He noted an improvement in vision as well as a reduction of 
photophobia despite not filling the homatropine prescription. The patient noted that 
the cost of the medication was too high. The pupils, EOMs and CVF were all 
unchanged. His vision had improved to 20/40+1 upon examination. The 
conjunctival injection had improved from 2+ to 1+ at this visit. The dendrites had 
gotten smaller but were still present. The importance of the oral valcyclovir was 
stressed and the patient was scheduled for a follow up visit 4 days later.  
 
FOLLOW UP #3  
 
  The patient made his final follow up on May 10th (after initially missing the 
scheduled follow up).  He had finished the course of valcyclovir and noted that his 
vision had returned to normal. The pupils, EOMs and CVFs were all stable. His 
vision had improved to 20/25. The conjunctival injection had improved from 1+ to 
trace injection. The dendrites had resolved with only trace superficial punctate 
keratitis present. The patient was presented with the option of continuing 
preventative treatment but declined noting the “I probably wouldn’t last a week 




  A subset of the Herpesviridae family Alphaherpesvirinae includes: Herpes 
Simplex type 1 (HSV-1), Herpes Simplex Type 2 (HSV-2), and Herpes Varicella 
Zoster (VZV) which are most pertinent for this discussion.3All three are double 
stranded DNA.3 Present throughout the world, and with humans as the only known 
natural reservoir, herpes is a virus faced by all humanity. Studies have shown that 
greater than 90% of the world’s population test positive for the presence of HSV-1 
within their trigeminal ganglia by the age of 60 years old. According to the United 
Nations Economic and social affairs, the population 60+ in 2015 was 901 million 
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people and is expected to rise to 1.4 billion by the year 2030.4 We can extrapolate 
that, by those numbers, 1.26 billion people will test positive for the HSV-1 virus 
within their trigeminal ganglion by the year 2030. Presence of HSV-1 within the 
trigeminal ganglion does not necessarily indicate ocular complications. Herpes 
Simplex Virus type 1 is responsible for oral infections, (commonly seen as “cold 
sores) and is most frequently spread by oral-to-oral contact. The second virus HSV-
2 is spread through sexual contact and can result in genital sores. Although rare, the 
HSV-1 virus can also cause genital herpes.4 
 
  Once someone has the virus, its appearance anywhere along the trigeminal 
dermatome can be triggered by stress, fever, trauma, or ultraviolet exposure.1-4 
Activation of the HSV-1 virus can affect skin/ eyelid, conjunctiva, cornea, anterior 
chamber, or retina.  
 
  Transmission of the virus can occur through mechanical transfer from a localized 
skin infection during the approximately 10 days it takes for the lesion to resolve. 
The viral load can also be high enough in the saliva of an asymptomatic person that 
contact with their saliva may be enough to transfer the virus to another person.1,4 
Additionally, Kaufman et al. revealed that 98% of asymptomatic HSV-infected 
patients secreted HSV-1 in either their tears or saliva.9 Of the 50 patients sampled 
13/50 (26%) were IgG negative for HSV-1, thus, suggesting that seronegative 
patients may have HSV present in either the trigeminal and/ or dorsal root ganglia.4 
 
 
Figure 2.3 Trigeminal Nerve Pathway 
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                 A localized HSV-1 infection of the eyelid can be seen below7  
                         
 
  Here we see small, localized elevations of the skin. They are a group of vesicles 
with reddening of the tissue deep to them. The lesions have a scalloped border and 
often have a “crust” due to fluid seepage. They tend to occur and then reoccur in 




  There are a variety of terms describing a herpes infection of the cornea. The 
language used varies from provider to provider and between different disciplines. 
Table 1 (below) summarizes the location involved as well as terms used to describe 
it.4  
 
 Corneal Layer  Nomenclature  Alternate Terms 
 Epithelium  HSV epithelial keratitis 
Dendritic epithelial ulcer 
Geographic epithelial 
ulcer 
 Stroma  
 HSV stromal keratitis 
without ulceration 
 
 HSV stromal keratitis 
with ulceration 
Non-necrotizing keratitis, 
Interstitial keratitis,  
Immune stromal keratitis 
 Necrotizing keratitis 
 Endothelium  HSV endothelial keratitis  Disciform keratitis 
TABLE 1. HSV KERATITIS: CLASSIFICATION 











  The corneal epithelium is involved in up to 2/3 of cases that present with ocular 
involvement. Early lesions appear as superficial punctate keratitis which can form 
into a dendrite within 12-24 hours. The dendrites form as the infected cell nuclei 
expand with increasing concentrations of the replicated virus. These cells swell 
until they burst, releasing high concentrations of the virus to neighboring cells. 
1,10The anatomic effect of the way the virus is passed is what provides “true 
dendrites” with their classical “terminal bulbs.” The terminal bulbs are cells that 
are swollen with virus that have not yet burst. If the infection continues to spread 
through the epithelium it can lead to the destruction of the basement membrane. As 
the basement membrane is responsible for maintaining the bond between the stroma 
and endothelium, its erosion can lead to the formation of a “geographic ulcer.” If 
the infection occurs near the limbus, the patient may be more symptomatic and may 
take longer to respond to treatment. Damage to the cornea may result in the patient 
suffering from recurrent corneal erosions or epithelial granularity. Opportunistic 
infection may exacerbate the presentation, mandating further treatment. 




HSV-1 within the stroma causes swelling within the endothelium. It may present 
either 1) with or without epithelial ulceration. The presence (or lack) of ulceration 
allows us to decide whether the addition of topical steroids would be helpful. Severe 
inflammation within the stroma can result in destruction and thinning of the corneal 
stroma. This inflammation may even result in perforation of the cornea, although 
that is uncommon unless another bacterial infection is also present. Stromal 
neovascularization may also occur, and this may present in either a sectoral or 




Inflammation of the endothelium is much less common than stromal inflammation 
but may be present. There is difficulty in determining whether the edema present is 
from a swelling of the stroma or endothelialitis. When endothelial edema is present 
it tends to appear as a round swelling occupying the central or paracentral cornea. 
It may be represented via a “ground glass” appearance. A linear endothelitis may 
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Iridocorneal Endothelial Syndrome (ICE): 
   
  This condition was originally thought to have been a congenital abnormality 
however it has been recently considered to be a result of HSV-1. ICE typically 
presents with unilateral corneal edema, corectopia and presumed trabecular 
abnormalities. The abnormal trabeculum is responsible for poorly draining the 
aqueous thus resulting in an elevated intraocular pressure and potentially glaucoma. 





  Treatment involves either oral or topical antivirals. Oral antivirals include 
acyclovir, valacyclovir and famciclovir; topical medications: trifluridine and 
ganciclovir. See dosage chart below (Table 212).  
 
TABLE 212 DOSAGE CHART 
  
  Treatment can also include mechanical debridement the removal of affected cells 
would seem to be helpful in reducing the time it takes to the viral concentration to 
decrease. However, White and Chodosh reveal mixed results with this treatment 
modality.4 When applied it should be in concurrence with either topical or oral 
treatment. Further studies would be helpful in determining whether this helps to 
improve outcomes.  
 
Drug (Trade) Mechanism of Action 
(MOA) 
Dosage 
Acyclovir Interference with viral 
DNA synthesis 
400 mg 5x/day 
Valacyclovir (Valtrex) Prodrug for acyclovir 500 mg TID 
Famciclovir (Famvir) Inhibits DNA chain 
elongation 
250 mg TID 
Triflouridine 
(Viroptic®) 
Interference with viral 
DNA synthesis 
Q2H until reepithelization 
(10-14 days) 
Ganciclovir (Zirgan®) Interference with viral 
DNA synthesis and 
Inhibits DNA chain 
elongation 
5x/day until 
reepithelization, then TID 
x 1 week  
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  HSV can be an AIDs-defining opportunistic infection although the incidence of 
HSV keratitis between HIV positive and HIV negative patients is fairly equal.4 
Studies have found mixed results regarding a difference between presentation and 
duration of treatment when comparing HIV (+) and HIV (-) patients4. More 




  The Herpetic Eye Disease Study (HEDs) study (1998) found that there was some 
success in reducing recurrences of HSV keratitis and HSK stromal disease. In this 
study, the necessary dosage was 400 mg BID oral acyclovir. This led to a decrease 
in HSK recurrence of 45% and HSK stromal disease by 42%.1 However, there is 
some concern about the usage of acyclovir and a potential for the virus to become 
resistant.1,11 While the idea of preventing future occurrences of herpetic eye disease 
have been proven possible, Lairson et al. have shown in a cost benefit analysis that 
it would not be cost effective to try to treat every patient with herpetic keratitis with 
preventive medication. Prophylactic treatment is a valuable tool in the provider’s 





  Herpes simplex keratitis can present in varying degrees of severity depending on 
the individual case. The provider must take care to prescribe medication that can 
be obtained, and the patient may need to show patience for results, especially if 
immunocompromised. The use of corneal debridement may be considered on a 
case-by-case basis but hasn’t shown to result in any significant difference in patient 
outcomes.  Additionally, the option of prophylactic treatment should be discussed,  
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